Chinese manufacturing companies struggle to navigate complex IPO processes and regulatory requirements for Science and Technology Innovation Board listings

Chinese manufacturers and industrial companies face significant pain in understanding and executing the IPO process for China's Science and Technology Innovation Board (科创板), including regulatory compliance, valuation, pricing strategy, and disclosure requirements. Current solutions lack integrated guidance that combines regulatory expertise with market timing insights, forcing companies to rely on fragmented advisory services and outdated information.